Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes - A preliminary analysis of the NHANES 1999-2002 data

Ethnicity and Disease

Volumn 17, Issue 1, 2007, Pages 35-39

  Lin, Susan X ^a,c   Pi Sunyer, F Xavier ^b  

^a NewYork Presbyterian Hospital   (United States)

^b St Luke's Roosevelt Hospital Center ^*  (United States)

^c NONE   (United States)

Author keywords

Diabetes; Metabolic syndrome; Metabolic syndrome components; Prevalence; Racial differences

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; FIBRINOGEN;

ABDOMINAL OBESITY; ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FIBRINOGEN BLOOD LEVEL; HEALTH SURVEY; HISPANIC; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; PREVALENCE; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; UNITED STATES;

ADULT; AFRICAN AMERICANS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MEXICAN AMERICANS; NUTRITION SURVEYS; PREVALENCE; UNITED STATES;

EID: 33846926593     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26(11): 3153-3159.
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-689.
3. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716.
4. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med. 2004;164(10):1066-1076.
5. Bruno G, Merletti F, Biggeri A, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care. 2004;27(11):2689-2694.
6. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109(1):42-46.
7. Bonora E, Targher G, Formentini G, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med. 2004;21(1):52-58.
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287(3):356-359.
10. National Health and Nutrition Examination Survey Data: 2001-2002. US Dept Human Health and Services, Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/about/major/nhanes/ nhanes01-02.htm.
11. National Health and Nutrition Examination Survey Data: 1999-2000. US Department of Human Health and Services. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/about/major/nhanes/ nhanes99_00.htm.
12. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28(2):385-390.
13. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and Whites with non-insulin-dependent diabetes in the US population. Circulation. 1994;90(3):1185-1193.
14. Gardner CD, Winkleby MA, Fortmann SP. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). Am J Cardiol. 2000;86(3):299-304.
15. Werk EE Jr, Gonzalez JJ, Ranney JE. Lipid level differences and hypertension effect in Blacks and Whites with type II diabetes. Ethn Dis. 1993;3(3):242-249.
16. Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese Black vs White adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003;88(6):2534-2540.